retatrutide fda approval timeline 2025 New Phase 3 data just dropped 👀 Eli Lilly's trial reported average weight loss approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats Retatrutide FDA Approval Status: July

With the pivotal trial complete and TRANSCEND-T2D-1 adding diabetes-specific data, Eli Lilly is on track for NDA submission Q4 2026

Storage & Stability Before Reconstitution : Store lyophilized powder at -20C (-4F) in a cool, dry, and dark environment

Side effects Common gastrointestinal side effects of GLP-1 medications are nausea, vomiting, diarrhea, constipation, abdominal discomfort, and stomachache

B., Neogi, T., da Rocha Castelar-Pinheiro, G., Kapetanovic, M

"Semaglutide." Available at: [2] PMC Clinical Study (2024)

Its called Vita PLynxera GLP-1 Liquid Drops and it contains nothing but natural ingredients in order to be viable and effective for as many people as possible even people for whom GLP-1 meds are not suitable